Used in the synthesis of pharmaceutical intermediates, particularly in the development of fluorinated bioactive compounds. Its structure supports the creation of potent enzyme inhibitors due to the electron-withdrawing effect of the difluoroethyl group, enhancing metabolic stability and binding affinity. Commonly employed in medicinal chemistry for optimizing drug candidates targeting central nervous system disorders and oncology. Also serves as a ligand in catalytic reactions, facilitating cross-coupling processes in advanced organic synthesis.